The promise and peril of chemical probes
C.H. Arrowsmith(Princess Margaret Cancer Centre), James E. Audia(Constellation Pharmaceuticals (United States)), Christopher P. Austin(National Institutes of Health), Jonathan B. Baell(Monash University), Jonathan P. Bennett(Merck & Co., Inc., Rahway, NJ, USA (United States)), Julian Blagg(Institute of Cancer Research), C. Bountra(University of Oxford), Paul E. Brennan(University of Oxford), Peter J. Brown(Structural Genomics Consortium), Mark E. Bunnage(Pfizer (United States)), Carolyn Buser‐Doepner(GlaxoSmithKline (United States)), Robert M Campbell(Eli Lilly (United States)), Adrian J. Carter(Boehringer Ingelheim (Germany)), Philip Cohen(University of Dundee), Robert A. Copeland(Epizyme (United States)), Ben Cravatt(Scripps Research Institute), Jayme L. Dahlin(Mayo Clinic), Dashyant Dhanak(Janssen (United States)), A.M. Edwards(Structural Genomics Consortium), Mathias Frederiksen(Novartis (Switzerland)), Stephen V. Frye(University of North Carolina at Chapel Hill), Nathanael S. Gray(Harvard University), Charles E. Grimshaw(Takeda (United States)), David Hepworth(Pfizer (United States)), Trevor Howe(Janssen (United Kingdom)), K. Huber(Austrian Academy of Sciences), Jian Jin(Icahn School of Medicine at Mount Sinai), Stefan Knapp(University of Oxford), Joanne Kotz(Broad Institute), Ryan G. Kruger(GlaxoSmithKline (United States)), Derek Lowe(Vertex Pharmaceuticals (United States)), Mary M. Mader(Eli Lilly (United States)), Brian D. Marsden(University of Oxford), Anke Mueller‐Fahrnow(Bayer (Germany)), Susanne Müller(University of Oxford), Rónán C. O’Hagan(Merck & Co., Inc., Rahway, NJ, USA (United States)), John P. Overington(European Bioinformatics Institute), Dafydd R. Owen(Pfizer (United States)), Saul H. Rosenberg(AbbVie (United States)), Ruth A. Ross(University of Toronto), Bryan L. Roth(University of North Carolina at Chapel Hill), Matthieu Schapira(University of Toronto), Stuart L. Schreiber(Broad Institute), Brian K. Shoichet(University of California, San Francisco), M. Sundström(Karolinska University Hospital), Giulio Superti-Furga(Austrian Academy of Sciences), Jack Taunton(Howard Hughes Medical Institute), Leticia Toledo‐Sherman(CHDI Foundation), Chris Walpole(Structural Genomics Consortium), Michael A. Walters(University of Minnesota), Timothy M. Willson(University of North Carolina at Chapel Hill), Paul Workman(Institute of Cancer Research), Robert N. Young(Simon Fraser University), William J. Zuercher(University of North Carolina at Chapel Hill)
Cited by 847Open Access
Abstract
Chemical probes are powerful reagents with increasing impacts on biomedical research. However, probes of poor quality or that are used incorrectly generate misleading results. To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.
Related Papers
No related papers found
Powered by citation graph analysis